Http://www.aarkstore.com/reports/ambu-a-s-ambub-financial-and-strategic-analysis-review-62713.html

Ambu A/S (Ambu) is a medical device company engaged in the development

, manufacture and marketing of life supporting and diagnostic equipments and solutions catering to hospitals and rescue service providers. The companys business areas include Cardiology, Neurology, Respiratory Care, Immobilization and Training. Ambu is headquartered in Ballerup, Denmark. The company generates revenues through five business segments: Respiratory Care (represented 40% of its total revenues for the fiscal year 2009), Cardiology (33.5%), Neurology (12.3%), Training (7.2%) and Immobilization and Other products (7%).

Ambu A/S Key Recent Developments

May 05, 2010: Company Announcement no. 9 2009/10 - Interim report for Q2 and Q1-Q2 2009/10

Nov 25, 2009: Ambu Reports Net Profit Of DKK56 Million In Fiscal 2009

Oct 15, 2009: Oberlandesgericht Dsseldorf Delivers Judgment In German Patent Litigation Between LMA And Ambu

Oct 10, 2009: Ambu Opens New Entity, Ambu Australia

Oct 01, 2009: Ambu Announces New Four-Year Strategy, GPS Four

This comprehensive SWOT analysis of Ambu A/S provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company

For more information please contact :

http://www.aarkstore.com/reports/Ambu-A-S-AMBUB-Financial-and-Strategic-Analysis-Review-62713.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise

POST COMMENT

Durbanville Property: 6 Mistakes When Trading Up #3 Aarkstore Enterprise---ossur Hf. (ossr) - Financial And Strategic Analysis Review Aarkstore Enterprise---orthofix International N.v. (ofix) - Financial And Strategic Analysis Review Aarkstore Enterprise---abbott Laboratories (abt) - Financial And Strategic Analysis Review Aarkstore Enterprise---luxottica Group S.p.a. (lux) - Financial And Strategic Analysis Review Aarkstore Enterprise---ev3 Inc. (evvv) - Financial And Strategic Analysis Review Aarkstore Enterprise---william Demant Holding A/s (wdh) - Financial And Strategic Analysis Review Aarkstore Enterprise---eli Lilly And Company (lly) - Financial And Strategic Analysis Review Aarkstore Enterprise---cerner Corporation (cern) - Financial And Strategic Analysis Review Aarkstore Enterprise---cochlear Limited (coh) - Financial And Strategic Analysis Review Aarkstore Enterprise---isoft Group Limited (isf) - Financial And Strategic Analysis Review Aarkstore Enterprise---genzyme Corporation (genz) - Financial And Strategic Analysis Review Aarkstore Enterprise---angiodynamics, Inc. (ango) - Financial And Strategic Analysis Review